Bart Kiemeney made it to this year’s list of highly cited researchers. Researchers in this list are selected for their exceptional research performance and are regarded to have had a major impact on fellow scientists.The list was recently published by Clarivate Analytics, an American company that offers services in the area of scientific research (such as Web of Science). According to the creator of the list, the awarded researchers ‘have demonstrated significant influence through publication of multiple highly cited papers during the last decade’. They produced several publications in the years 2006-2016 that rank the top 1 % by citations.
Bart Kiemeney is classified in the new 'Cross-Field' category, meaning he has been cited in different fields. Clarivate Analytics wants to use this category to break down the “artificial walls of conventional disciplinary categories”.
The list of the 1 percent most cited scientists of the past ten years contains 14 researchers who are affiliated with Radboud University or Radboudumc.
Related news items
Young Radboudumc researchers receive grant to engage in bio-medical and health research that is off the beaten path16 September 2021
The ZonMw Off Road program is once again giving young scientists the opportunity to conduct innovative research in medical and/or health care. This research is off the beaten track and aims to bring about new insights and unexpected breakthroughs for healthcare and healthcare innovation.read more
Infections increase risk to develop dementia16 September 2021
In a recently published study, Radboudumc researchers investigated the effects of infectious events on cognitive decline and the development of dementia and its possible structural underpinning using pre- and post-infection MRI of the brain.read more
ENABLECARES launches a course on entrepreneurship for PhD candidates and postdocs15 September 2021
Are you thinking about what to do after your PhD? Want to know more about entrepreneurship? This course gives you insight in many aspects of entrepreneurship and research in industry.read more
Effectiveness and predictors of response to somatostatin analogues in patients with gastrointestinal angiodysplasias15 September 2021
Lia Goltstein and colleagues published a study about effectiveness and predictors of response to somatostatin analogues in patients with gastrointestinal angiodysplasias: a systematic review and individual patient data meta-analysis.read more